Home > Publications database > ITIH5 mediates epigenetic reprogramming of breast cancer cells > print

001     828247
005     20210129230036.0
024 7 _ |a 10.1186/s12943-017-0610-2
|2 doi
024 7 _ |a 2128/13964
|2 Handle
024 7 _ |a WOS:000397799800002
|2 WOS
024 7 _ |a altmetric:21833005
|2 altmetric
024 7 _ |a pmid:28231808
|2 pmid
037 _ _ |a FZJ-2017-02215
082 _ _ |a 610
100 1 _ |a Rose, Michael
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a ITIH5 mediates epigenetic reprogramming of breast cancer cells
260 _ _ |a London
|c 2017
|b Biomed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1490013284_21448
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Extracellular matrix (ECM) is known to maintain epithelial integrity. In carcinogenesis ECM degradation triggers metastasis by controlling migration and differentiation including cancer stem cell (CSC) characteristics. The ECM-modulator inter- α-trypsin inhibitor heavy chain family member five (ITIH5) was recently identified as tumor suppressor potentially involved in impairing breast cancer progression but molecular mechanisms underlying its function are still elusive.
536 _ _ |a 552 - Engineering Cell Function (POF3-552)
|0 G:(DE-HGF)POF3-552
|c POF3-552
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Kloten, Vera
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Noetzel, Erik
|0 P:(DE-Juel1)145698
|b 2
|u fzj
700 1 _ |a Gola, Lukas
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Ehling, Josef
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Heide, Timon
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Meurer, Steffen K.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Gaiko-Shcherbak, Aljona
|0 P:(DE-Juel1)156241
|b 7
|u fzj
700 1 _ |a Sechi, Antonio S.
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Huth, Sebastian
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Weiskirchen, Ralf
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Klaas, Oliver
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Antonopoulos, Wiebke
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Lin, Qiong
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Wagner, Wolfgang
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Veeck, Jürgen
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Gremse, Felix
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Steitz, Julia
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Knüchel, Ruth
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Dahl, Edgar
|0 P:(DE-HGF)0
|b 19
|e Corresponding author
773 _ _ |a 10.1186/s12943-017-0610-2
|g Vol. 16, no. 1, p. 44
|0 PERI:(DE-600)2091373-4
|n 1
|p 44
|t Molecular cancer
|v 16
|y 2017
|x 1476-4598
856 4 _ |u https://juser.fz-juelich.de/record/828247/files/art_10.1186_s12943-017-0610-2.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/828247/files/art_10.1186_s12943-017-0610-2.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/828247/files/art_10.1186_s12943-017-0610-2.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/828247/files/art_10.1186_s12943-017-0610-2.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/828247/files/art_10.1186_s12943-017-0610-2.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/828247/files/art_10.1186_s12943-017-0610-2.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:828247
|p openaire
|p open_access
|p driver
|p VDB
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)145698
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)156241
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-552
|2 G:(DE-HGF)POF3-500
|v Engineering Cell Function
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOL CANCER : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b MOL CANCER : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-7-20110106
|k ICS-7
|l Biomechanik
|x 0
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-7-20110106
981 _ _ |a I:(DE-Juel1)IBI-2-20200312

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21